We invest in companies where execution and domain knowledge actually matter. We stay close when those decisions count.
Built and scaled a clinical workflow company that was part of a $1.43 billion acquisition by Fortive.
That experience shapes how we invest. We know what it costs to build in regulated markets — the compliance burden, the sales cycles, the integration politics. We have been inside the decisions founders face and we are not guessing about what matters.
Markets where complexity is structural — where we have built, exited, and continued to invest.
Operator experience.
Selective capital.
Long-term alignment.
We invest across the full early-stage arc — from pre-seed companies finding product-market fit to Series A companies scaling into their market. We follow conviction, not stage.
We bring operating judgment built from building in healthcare IT — a market that punishes anyone who does not understand the buyer, the compliance reality, or the integration.
If you are building where the complexity is real and the execution has to be exact, we should talk.
Practicing physician with deep experience at the intersection of clinical care and health technology. Brings firsthand clinical validation — from workflow fit to real-world adoption — to every healthcare investment.
Seasoned technology executive with enterprise software and platform architecture expertise. Evaluates product depth and technical scalability — helping founders pressure-test decisions before they become expensive.
For founders, co-investors, and select opportunities.
We review everything that comes in. If there is a fit, we respond quickly. We'll ask for a deck if we want to learn more.